Literature DB >> 7050050

Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review.

D W Siemann.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7050050     DOI: 10.1016/0360-3016(82)90172-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  21 in total

Review 1.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

2.  5-Fluorouracil-metronidazole combination therapy in metastatic colorectal cancer. Clinical, pharmacokinetic and in vitro cytotoxicity studies.

Authors:  Z Bardakji; J Jolivet; Y Langelier; J G Besner; J Ayoub
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.

Authors:  B A Teicher; T S Herman; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

5.  Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.

Authors:  K A Smith; S A Hill; A C Begg; J Denekamp
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

6.  In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.

Authors:  D W Siemann; K Wolf; S Morrissey; K T Wheeler
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

7.  Chemopotentiation of CCNU metabolites by misonidazole.

Authors:  R T Mulcahy
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

8.  Preclinical pharmacokinetics of benznidazole.

Authors:  P Workman; R A White; M I Walton; L N Owen; P R Twentyman
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

9.  Chemopotentiation in vivo: no loss of sensitization with fractionation.

Authors:  S A Hill; D W Siemann
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

10.  Factors influencing the chemosensitization of melphalan by misonidazole.

Authors:  V S Randhawa; F A Stewart; J Denekamp; M R Stratford
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.